Comparison of Priority vs Standard US Food and Drug Administration Premarket Approval Review for High-Risk Medical Devices

Παρόμοια τεκμήρια

• Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements
  ανά: Zheng, Sarah Y., κ.ά.
  Έκδοση: (2017)
• Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications
  ανά: Lee, Samuel J., κ.ά.
  Έκδοση: (2021)
• Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program
  ανά: Jones, L. Camille, κ.ά.
  Έκδοση: (2018)
• Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices
  ανά: Dhruva, Sanket S., κ.ά.
  Έκδοση: (2017)
• Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017
  ανά: Dubin, Jonathan R., κ.ά.
  Έκδοση: (2021)